Inhibition by forskolin of insulin-stimulated glucose transport in L6 muscle cells.

Por Klip, A, Ramlal, T, Douen, A G, Bilan, P J, Skorecki, K L
Publicado em 1988

Epidermal growth factor stimulates phospholipase A2 in vasopressin-treated rat glomerular mesangial cells.

Por Margolis, B L, Holub, B J, Troyer, D A, Skorecki, K L
Publicado em 1988

Distinct structural specificities for functional coupling of the epidermal growth factor receptor to calcium-signalling versus phospholipase A2 responses.

Por Hack, N, Margolis, B L, Ullrich, A, Schlessinger, J, Skorecki, K L
Publicado em 1991

Reversible captopril-associated bone marrow aplasia.

Por Strair, R K, Mitch, W E, Faller, D V, Skorecki, K L
Publicado em 1985

Position effect of human telomeric repeats on replication timing

Por Ofir, R., Wong, A. C. C., McDermid, H. E., Skorecki, K. L., Selig, S.
Publicado em 1999

The tyrosine kinase activity of the epidermal-growth-factor receptor is necessary for phospholipase A2 activation.

Por Goldberg, H J, Viegas, M M, Margolis, B L, Schlessinger, J, Skorecki, K L
Publicado em 1990

Epidermal growth factor is synergistic with phorbol esters and vasopressin in stimulating arachidonate release and prostaglandin production in renal glomerular mesangial cells.

Por Margolis, B L, Bonventre, J V, Kremer, S G, Kudlow, J E, Skorecki, K L
Publicado em 1988

Epidermal growth factor and phorbol myristate acetate increase expression of the mRNA for cytosolic phospholipase A2 in glomerular mesangial cells.

Por Maxwell, A P, Goldberg, H J, Tay, A H, Li, Z G, Arbus, G S, Skorecki, K L
Publicado em 1993